{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:24:50Z","timestamp":1791498290503,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.amjcard.2012.02.045","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T18:02:21Z","timestamp":1333044141000},"page":"30-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of Additional Versus No Additional Heparin During Therapeutic Oral Anticoagulation in Patients Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"110","author":[{"given":"Tuomas","family":"Kiviniemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Karjalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Pietil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Ylitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Niemel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saila","family":"Vikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Puurunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Biancari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari Eino Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2012.02.045_bib1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","volume":"31","author":"Lip","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.02.045_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/eurheartj\/ehn099","article-title":"Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment","volume":"29","author":"Karjalainen","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.02.045_bib3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1378\/chest.09-2603","article-title":"Safety of uninterrupted anticoagulation in patients requiring elective coronary angiography with or without percutaneous coronary intervention: a systematic review and metaanalysis","volume":"138","author":"Jamula","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2012.02.045_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4244\/EIJ30V6I4A86","article-title":"How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to \u201cbridge\u201d or not to \u201cbridge\u201d?","volume":"6","author":"Airaksinen","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2012.02.045_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.amjcard.2010.03.011","article-title":"Usefulness of outpatient bleeding risk index to predict bleeding complications in patients with long-term oral anticoagulation undergoing coronary stenting","volume":"106","author":"Airaksinen","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.02.045_bib6","article-title":"Long-term safety of drug-eluting stents in patients on warfarin treatment","author":"Annala","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.amjcard.2012.02.045_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.jvca.2011.09.024","article-title":"Timing of preoperative aspirin discontinuation and outcome after elective coronary artery bypass graft surgery","volume":"26","author":"Mikkola","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.amjcard.2012.02.045_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.thromres.2011.05.021","article-title":"Safety of coronary artery bypass surgery during therapeutic oral anticoagulation","volume":"128","author":"Airaksinen","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2012.02.045_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis In Myocardial Infarction (TIMI) trial\u2014phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.02.045_bib10","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitionss","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.02.045_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Statist"},{"key":"10.1016\/j.amjcard.2012.02.045_bib12","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.amjcard.2008.08.021","article-title":"Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy","volume":"102","author":"Rossini","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2012.02.045_bib13","article-title":"The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries","author":"Rubboli","year":"2011","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.amjcard.2012.02.045_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-8703(98)70223-6","article-title":"How does warfarin affect the activated coagulation time?","volume":"136","author":"Chang","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2012.02.045_bib15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jacc.2008.07.026","article-title":"The CIAO (Coronary Interventions Antiplatelet-based Only) Study: a randomized study comparing standard anticoagulation regimen to absence of anticoagulation for elective percutaneous coronary intervention","volume":"52","author":"Stabile","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2012.02.045_bib16","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.103.16.2042","article-title":"Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications","volume":"103","author":"ten Berg","year":"2001","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491200848X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491200848X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:23:53Z","timestamp":1757571833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291491200848X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S000291491200848X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.02.045","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Additional Versus No Additional Heparin During Therapeutic Oral Anticoagulation in Patients Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.02.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}